Infliximab therapy modulates an antigen-specific immune response in chronic beryllium disease.

ABSTRACT:

SUBMITTER: Maier LA 

PROVIDER: S-EPMC4347848 | biostudies-literature | 2012 Dec

REPOSITORIES: biostudies-literature